TYSABRI for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 198 adverse event reports in the FDA FAERS database where TYSABRI was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for TYSABRI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 811 | 9.9% | 8 | 241 |
| Fatigue | 759 | 9.2% | 0 | 56 |
| Malaise | 523 | 6.4% | 1 | 37 |
| Gait disturbance | 445 | 5.4% | 2 | 32 |
| Multiple sclerosis | 443 | 5.4% | 9 | 57 |
| Memory impairment | 422 | 5.1% | 0 | 26 |
| Headache | 368 | 4.5% | 0 | 34 |
| Drug ineffective | 329 | 4.0% | 2 | 25 |
| Asthenia | 328 | 4.0% | 3 | 49 |
| Fall | 324 | 4.0% | 8 | 99 |
| Nasopharyngitis | 310 | 3.8% | 0 | 14 |
| Urinary tract infection | 308 | 3.8% | 12 | 117 |
| Pain | 274 | 3.3% | 1 | 37 |
| Balance disorder | 260 | 3.2% | 1 | 25 |
| Hypoaesthesia | 259 | 3.2% | 0 | 32 |
Other Indications for TYSABRI
Multiple sclerosis (7,629)
Product used for unknown indication (190)
Crohn's disease (157)
Maternal exposure timing unspecified (15)
Exposure via father (5)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)